Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
RENN Fund, Inc. (RCG)
Sector: Financial Services; Industry: Asset Management

RENN Fund, Inc. is a closed ended equity mutual fund launched by RENN Capital Group, Inc. The fund is co-managed by Horizon Kinetics Asset Management LLC. The fund seeks to invest in stocks of companies operating across diversified sectors. It seeks to invest in stocks of small-cap and mid-cap companies. The fund employs a fundamental analysis with a bottom-up stock picking approach to create its portfolio.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-29 STAHL MURRAY President & CEO Buy 675 $1.69 $1,142 No
2020-12-28 STAHL MURRAY President and CEO Buy 675 $1.67 $1,130 No
2020-12-24 STAHL MURRAY President and CEO Buy 1,350 $1.66 $2,236 No
2020-12-22 STAHL MURRAY President and CEO Buy 725 $1.63 $1,180 No
2020-12-21 STAHL MURRAY President and CEO Buy 675 $1.63 $1,099 No
2020-12-18 STAHL MURRAY President and CEO Buy 725 $1.59 $1,154 No
2020-12-17 STAHL MURRAY President & CEO Buy 675 $1.61 $1,089 No
2020-12-16 STAHL MURRAY President & CEO Buy 675 $1.68 $1,132 No
2020-12-15 STAHL MURRAY President and CEO Buy 675 $1.60 $1,080 No
2020-12-14 STAHL MURRAY President and CEO Buy 675 $1.69 $1,138 No
2020-12-11 STAHL MURRAY President and CEO Buy 675 $1.69 $1,141 No
2020-12-10 STAHL MURRAY President & CEO Buy 675 $1.67 $1,124 No
2020-12-09 STAHL MURRAY President and CEO Buy 675 $1.66 $1,117 No
2020-12-08 STAHL MURRAY President and CEO Buy 675 $1.68 $1,131 No
2020-12-07 STAHL MURRAY President and CEO Buy 675 $1.69 $1,137 No
2020-12-04 STAHL MURRAY President and CEO Buy 675 $1.61 $1,087 No
2020-12-03 STAHL MURRAY President and CEO Buy 675 $1.58 $1,066 No
2020-12-02 STAHL MURRAY President and CEO Buy 675 $1.57 $1,060 No
2020-12-01 STAHL MURRAY President and CEO Buy 713 $1.59 $1,134 No
2020-11-30 STAHL MURRAY President and CEO Buy 675 $1.58 $1,063 No
2020-11-27 STAHL MURRAY President & CEO Buy 675 $1.57 $1,056 No
2020-11-25 STAHL MURRAY President and CEO Buy 675 $1.54 $1,037 No
2020-11-24 STAHL MURRAY President and CEO Buy 675 $1.58 $1,069 No
2020-11-23 STAHL MURRAY President and CEO Buy 675 $1.51 $1,019 No
2020-11-20 STAHL MURRAY President and CEO Buy 675 $1.56 $1,056 No
2020-11-19 STAHL MURRAY President & CEO Buy 675 $1.56 $1,054 No
2020-11-18 STAHL MURRAY President & CEO Buy 675 $1.56 $1,050 No
2020-11-17 STAHL MURRAY President and CEO Buy 675 $1.57 $1,060 No
2020-11-16 STAHL MURRAY President and CEO Buy 675 $1.53 $1,029 No
2020-11-13 STAHL MURRAY President and CEO Buy 675 $1.47 $992 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.